GlassScriptPhysician profile
Laura Horan
NPI 1962438986
$2,221.44
in general payments reported to CMS, 2019-2025
18 companies · $520 in 2025
The $520 reported for 2025 was more than what 84% of Obstetrics & Gynecology (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Obstetrics & Gynecology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $145 · 2022: $1,206 · 2023: $90.15 · 2024: $260 · 2025: $520.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $871.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $870.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scynexis, INC. | $873.55 | 2022 | |
| Abbvie INC. | $242.27 | 2021-2025 | |
| Mayne Pharma Commercial LLC | $213.52 | 2023-2025 | |
| Sage Therapeutics, LLC | $177.02 | 2024-2025 | Zurzuvae |
| Evofem Biosciences, INC. | $175.01 | 2021-2025 | Solosec, Phexx, Phexxi |
| Boston Scientific Corporation | $112.64 | 2025 | Advantage System |
| Sumitomo Pharma America, INC. | $65.07 | 2024-2025 | Myfembree |
| Astellas Pharma US INC | $57.44 | 2024-2025 | Veozah |
| Therapeuticsmd, INC. | $57.03 | 2022 | |
| Coopersurgical, INC. | $53.96 | 2023-2024 | Paragard T 380a, Paragard T 380a |
| Vertex Pharmaceuticals Incorporated | $42.81 | 2024-2025 | |
| Hologic Sales and Service, LLC | $34.34 | 2023-2025 | Thinprep 2000 Processor, Aptima, Affirm Prone Biopsy System |
| Organon LLC | $26.62 | 2022 | |
| Supernus Pharmaceuticals, INC. | $22.69 | 2025 | Qelbree |
| Medtronic, INC. | $20.21 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $17.19 | 2021 | |
| Myovant Sciences INC. | $16.17 | 2022 | |
| Millicent US INC | $13.90 | 2025 | Femring, Intrarosa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Horan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.